Journal of Medicinal Chemistry · 2018 · 13 citations · 15 references
PharmacyMedicinal ChemistryMolecular BiologyDrug DesignDrug DiscoveryLead OptimizationFragment-based Lead DiscoveryHit-to-lead OptimizationHit-to-lead ProgressionLead Compound DesignLead DiscoveryPotency OptimizationBinding Mode AnalysisBinding Mode OptimizationKinase Inhibitor Library DesignPhosphoinositide 3-Kinase Delta InhibitorsPi3k InhibitorsPi3k SignalingStructure-based Lead DiscoveryStructure-guided Lead Discovery
A deconstruction of previously reported phosphoinositide 3-kinase δ (PI3Kδ) inhibitors and subsequent regrowth led to the identification of a privileged fragment for PI3Kδ, which was exploited to deliver a potent, efficient, and selective lead series with a novel binding mode observed in the PI3Kδ crystal structure.
15
Kenneth Down, Augustin Amour, Angela M. Deakin et al. · Journal of Medicinal Chemistry · 2015 · 132 citations